Date:10/08/2007 URL: http://www.thehindu.com/2007/08/10/stories/2007081056951800.htm

Business - Briefly

Biocon in pact with Abraxis Bioscience

MUMBAI: Biocon and Abraxis BioScience Inc., an integrated global biopharmaceutical company, have announced a licensing agreement for the commercialisation of Abraxane (paclitaxel protein-bound particles for injectable suspension) (albumin-bound) in India. Under the agreement, Biocon will also have the right to market Abraxane in Pakistan, Bangladesh, Sri Lanka, UAE, Saudi Arabia, Kuwait and certain other Persian Gulf countries.